LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice

Qingshuang Cai, Rajesh Sahu, Vanessa Ueberschlag-Pitiot, Sirine Souali-Crespo, Céline Charvet, Ilyes Silem, Félicie Cottard, Tao Ye, Fatima Taleb, Eric Metzger, Roland Schuele, Isabelle M. L. Billas, Gilles Laverny, Daniel Metzger and Delphine Duteil ()
Additional contact information
Qingshuang Cai: IGBMC UMR 7104- UMR-S 1258
Rajesh Sahu: IGBMC UMR 7104- UMR-S 1258
Vanessa Ueberschlag-Pitiot: IGBMC UMR 7104- UMR-S 1258
Sirine Souali-Crespo: IGBMC UMR 7104- UMR-S 1258
Céline Charvet: IGBMC UMR 7104- UMR-S 1258
Ilyes Silem: IGBMC UMR 7104- UMR-S 1258
Félicie Cottard: IGBMC UMR 7104- UMR-S 1258
Tao Ye: IGBMC UMR 7104- UMR-S 1258
Fatima Taleb: IGBMC UMR 7104- UMR-S 1258
Eric Metzger: Klinikum der Albert-Ludwigs-Universität Freiburg
Roland Schuele: Klinikum der Albert-Ludwigs-Universität Freiburg
Isabelle M. L. Billas: IGBMC UMR 7104- UMR-S 1258
Gilles Laverny: IGBMC UMR 7104- UMR-S 1258
Daniel Metzger: IGBMC UMR 7104- UMR-S 1258
Delphine Duteil: IGBMC UMR 7104- UMR-S 1258

Nature Communications, 2024, vol. 15, issue 1, 1-19

Abstract: Abstract Synthetic glucocorticoids (GC), such as dexamethasone, are extensively used to treat chronic inflammation and autoimmune disorders. However, long-term treatments are limited by various side effects, including muscle atrophy. GC activities are mediated by the glucocorticoid receptor (GR), that regulates target gene expression in various tissues in association with cell-specific co-regulators. Here we show that GR and the lysine-specific demethylase 1 (LSD1) interact in myofibers of male mice, and that LSD1 connects GR-bound enhancers with NRF1-associated promoters to stimulate target gene expression. In addition, we unravel that LSD1 demethylase activity is required for triggering starvation- and dexamethasone-induced skeletal muscle proteolysis in collaboration with GR. Importantly, inhibition of LSD1 circumvents muscle wasting induced by pharmacological levels of dexamethasone, without affecting their anti-inflammatory activities. Thus, our findings provide mechanistic insights into the muscle-specific GC activities, and highlight the therapeutic potential of targeting GR co-regulators to limit corticotherapy-induced side effects.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-47846-9 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-47846-9

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-47846-9

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().